With surveillance, conversion to acute valve syndrome happened frequently and was linked to worse clinical outcomes.

The system, which has received CE Mark approval in Europe, adds to an increasingly crowded field of PFA technologies.

AI outperformed clinicians and almost matched hs-TnT testing, but one expert questioned if this is where it’s needed most.